• OPEN AN ACCOUNT
A+| A| A-|
Indian Indices
Sensex
77,328.19 -516.33
( -0.66%)
Global Indices
Nasdaq
49,628.48 -303.12
(-0.61%)
Dow Jones
7,359.75 -26.37
(-0.36%)
Hang Seng
62,681.30 -152.54
(-0.24%)
Nikkei 225
10,228.01 -48.94
(-0.48%)
Forex
USD-INR
94.67 -0.51
(-0.53%)
EUR-INR
111.19 -0.10
(-0.09%)
GBP-INR
128.70 -0.19
(-0.14%)
JPY-INR
0.60 0.00
(0.12%)

EQUITY - MARKET SCREENER

Godavari Drugs Ltd
Industry :  Pharmaceuticals - Indian - Bulk Drugs
BSE Code
ISIN Demat
Book Value()
530317
INE362C01012
65.6225604
NSE Symbol
P/E(TTM)
Mar.Cap( Cr.)
N.A
29.33
127.71
EPS(TTM)
Face Value()
Div & Yield %
4.3
10
0
 

nestle india ltd
National Standard (India) standalone net profit declines 67.78% in the March 2026 quarter
Apr 18,2026
Net profit of National Standard (India) declined 67.78% to Rs 1.16 crore in the quarter ended March 2026 as against Rs 3.60 crore during the previous quarter ended March 2025. There were no Sales reported in the quarter ended March 2026 as against Rs 2.81 crore during the previous quarter ended March 2025.

For the full year,net profit declined 26.82% to Rs 9.66 crore in the year ended March 2026 as against Rs 13.20 crore during the previous year ended March 2025. Sales declined 8.55% to Rs 20.42 crore in the year ended March 2026 as against Rs 22.33 crore during the previous year ended March 2025.

ParticularsQuarter EndedYear Ended
Mar. 2026Mar. 2025% Var.Mar. 2026Mar. 2025% Var.
Sales02.81 -100 20.4222.33 -9
OPM %0-3.56 --30.660.72 -
PBDT1.654.91 -66 13.2818.29 -27
PBT1.654.89 -66 13.2818.27 -27
NP1.163.60 -68 9.6613.20 -27